CORE--FLOW CYTOMETRY AND CELL SORTING

流式细胞术和细胞分选设备由癌症中心于1980年建立。自1981年以来，它一直得到NCI核心支助赠款的批准和资助。Jonni摩尔博士自1990年以来一直指导流式细胞术和细胞分选设备。摩尔博士拥有免疫学博士学位和超过十五年的流式细胞术经验，并担任流式细胞术设备制造商的专家顾问（即，Becton Dickinson）和其他流式细胞术实验室（例如，SmithKline Beecham，Merck）。Charles Pletcher，MCI技术总监，自1987年以来一直在该设施工作。在本项目期间，该基金得到了极大的发展。这是由于在收购新技术和招聘专家人员期间进行了重大运营改进。在本项目期间购买的设备（FACSVantage和FACSCalibur），使其具备了与最先进的流式细胞仪设施相当的能力。在本项目期间，核心的总使用量增加了67%。癌症中心成员的使用率为77%，所有癌症中心成员的使用率为86%。

The Flow Cytometry and Cell Sorting Facility was established by the Cancer Center in 1980. It has been continuously approved and funded by the NCI Core Support Grant since 1981. Jonni Moore, PhD, has directed the Flow Cytometry and Cell Sorting Facility since 1990. Dr. Moore has a doctorate in immunology and over fifteen years of flow cytometry experience, and serves as an expert consultant to manufacturers of flow cytometry equipment (i.e., Becton Dickinson) and to other flow cytometry laboratories (e.g., SmithKline Beecham, Merck). Charles Pletcher, MCI, Technical Director has been with the Facility since 1987. The Facility has grown tremendously during the current project period. This has resulted from major operational improvements, during acquisition of newer technology, and recruitment of expert staff. With the equipment purchased during the current project period (FACSVantage and FACSCalibur), it now possesses capabilities equal to those of the most sophisticated flow cytometry facilities. Overall usage of the core has increased 67% during the current project period. Usage by Cancer Center members with peer-reviewed funding is 77% and usage by all Cancer Center members is 86% of total facility usage.